Darwin Molecular
Facts
- HQ
- Seattle
- Sectors
- Biotechnology, Life Sciences
- Founded
- 1992
Is this your organization? Claim it
Mary Brunkow’s work identifying a gene that keeps T cells in check helped her share the Nobel Prize in Medicine
Mary Brunkow’s curiosity led her from fruit-fly genetics at the University of Washington to Seattle biotech work identifying a gene that regulates T cells, a discovery that contributed to her sharing the Nobel Prize in Medicine.
Mary Brunkow wins 2025 Nobel Prize after gene discovery at Darwin Molecular reveals T‑cell role in autoimmune disease
Mary Brunkow’s path from an inspiring undergraduate lab experience to leading research at Darwin Molecular culminated in a Nobel Prize for work that traced a gene linked to severe autoimmune disease and revealed new insights into T cells.
Mary Brunkow shares 2025 Nobel Prize in Medicine for identifying gene that prevents autoimmune attacks
Mary Brunkow’s curiosity led her from fruit-fly genetics at the University of Washington to work at Seattle biotech Darwin Molecular, where she helped identify a gene that keeps the immune system in check and later shared the 2025 Nobel Prize in Medicine for discoveries explaining how the immune system avoids attacking the body’s own tissues.
Questions about Darwin Molecular
What is Darwin Molecular?
Darwin Molecular is a former startup based in Seattle.
Where is Darwin Molecular based?
Darwin Molecular is based in Seattle.
When was Darwin Molecular founded?
Darwin Molecular was founded in 1992.